Immuron Limited - ADR

:IMRN 10:24:06 AM EDT

1.65

-0.15 (-8.33%)

Market Cap (Intraday)	13.32M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.4 Million
Adjusted EPS	$0.00

See more estimates

10-Day MA	$1.32
50-Day MA	$1.16
200-Day MA	$1.02

See more pivots

Immuron Limited - ADR Stock, :IMRN

Building 10, 25-37 Chapman Street, Blackburn North, Victoria (VIC) 3131

Australia

Phone: +61.3.8892.4802

Number of Employees:

http://www.immuron.com

Description

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. Its proprietary technology is based on polyclonal immunoglobulins derived from engineered hyper-immune bovine colostrum. This technology can be used to target viruses or bacteria and neutralize the toxins they produce on mucosal surfaces. It operates through the Research and Development, and Hyperimmune Products segments. The Research and Development segment includes projects performed in Australia and United States. The Hyperimmune Products segment is composed of Travelan, and Protectyn activities which occur in Australia, United States, and rest of the world. The company was founded on January 13, 1994, and is headquartered in Carlton, Australia.